Tirzepatide is particularly notable because it targets two hormones (GIP and GLP-1), making it potentially more potent than older GLP-1s
However, hepatic production of cysteine is limited and cysteine-deficient status is associated with numerous diseases such as insulin resistance, immune dysfunction and cancer 1
Approval was supported by the OASIS 4 phase 3 clinical trial, which followed 307 participants without diabetes for 64 weeks
Design This was a randomized, double-blind, placebo-controlled clinical trial
The same rule applies when comparing 25 mg, 50 mg, and 100 mg tablets, because the total depends on the strength shown and the quantity chosen
Katharina Spies from Vida Fertility